Healthcare Services

Glioblastoma Multiforme (GBM) Treatment Market Developments and Growth Opportunities Across 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Glioblastoma Multiforme (GBM) Treatment Market From 2026 To 2030?

The glioblastoma multiforme (gbm) treatment market size has witnessed significant expansion in recent years. This market is anticipated to expand from $2.73 billion in 2025 to $3.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.7%. The historical growth of this market can be attributed to factors like limited survival outcomes, reliance on surgery and radiation, chemotherapy standardization, the growth of neuro-oncology centers, and an increased diagnosis of brain tumors.

The glioblastoma multiforme (gbm) treatment market size is anticipated to experience substantial growth over the upcoming years. It is forecast to expand to $4.46 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.2%. This expected expansion during the forecast period is primarily due to the progress in developing targeted therapies, the enlargement of immunotherapy pipelines, the adoption of precision medicine, a surge in clinical trial activity, and increasing research funding. Significant trends for the forecast period include the rising acceptance of multimodal treatment regimens, a greater utilization of tumor treating field therapy, an intensified focus on personalized gbm therapies, the broadening of immunotherapy approaches, and improved post-surgical treatment protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp

What Key Drivers Are Influencing The Growth Of The Glioblastoma Multiforme (GBM) Treatment Market?

The rising incidence of brain disorders is projected to boost the expansion of the glioblastoma multiforme (GBM) treatment market. Brain disorders are characterized by atypical functioning of the brain, as well as the nerves throughout the human body and the spinal cord. The growing occurrence of brain disorders, including glioblastoma multiforme (GBM), is attributed to multiple contributing factors such as an aging population, compromised immune systems, overdiagnosis, ionizing radiation, and air pollution, thereby creating a demand for treatment to enhance overall well-being. For instance, in February 2025, Dementia Australia, an Australia-based non-profit organization, reported approximately 433,300 Australians living with dementia, with this figure anticipated to increase to 812,500 by 2054. Moreover, younger-onset dementia affects around 29,000 people in 2025, with projections indicating an increase to 41,000 by 2054. Consequently, the increasing prevalence of brain disorders is driving the growth of the glioblastoma multiforme (GBM) treatment market.

Which Segments Are Included In The Analysis Of The Glioblastoma Multiforme (GBM) Treatment Market?

The glioblastoma multiforme (gbm) treatment market covered in this report is segmented –

1) By Treatment: Surgery, Radiation Therapy, Chemotherapy, R Immunotherapy

2) By Drug Class: Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Other Drug Classes

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Surgery: Tumor Resection, Biopsy Procedures

2) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Stereotactic Radiation Therapy

3) By Chemotherapy: Standard Chemotherapy, Combination Chemotherapy Regimens

4) By Immunotherapy: Checkpoint Inhibitors, Vaccine-Based Therapies

What Key Developments And Trends Are Impacting The Glioblastoma Multiforme (GBM) Treatment Market?

Leading companies in the market are concentrating on developing innovative wearable and portable devices to maintain their competitive standing. These advancements are designed to offer users enhanced functionality, convenience, and comfort, addressing the increasing demand for accessible and efficient healthcare solutions. For instance, in 2023, Novocure, a Jersey-based oncology company, introduced Optune Gio, a wearable and portable treatment system approved by the FDA for patients recently diagnosed with glioblastoma (GBM). This device utilizes Tumor Treating Fields (TTFields), which are alternating electric fields that interfere with cancer cell division, potentially extending patient survival. Weighing only 2.7 pounds, Optune Gio is engineered for comfort, allowing patients to wear it throughout their daily activities.

Which Key Industry Participants Are Active In The Glioblastoma Multiforme (GBM) Treatment Market?

Major companies operating in the glioblastoma multiforme (gbm) treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Jazz Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Varian Medical Systems Inc., Amneal Pharmaceuticals Inc., Elekta AB, Loxo Oncology Inc., Karyopharm Therapeutics Inc., EnGeneIC Ltd., Genenta Science S.r.l., Cantex Pharmaceuticals Inc., Vascular Biogenics Ltd., Seelos Therapeutics Inc, Angiochem Inc., Diffusion Pharmaceuticals Inc

Read the full glioblastoma multiforme (gbm) treatment market report here:

https://www.thebusinessresearchcompany.com/report/glioblastoma-multiforme-gbm-treatment-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Glioblastoma Multiforme (GBM) Treatment Market?

North America was the largest region in the glioblastoma multiforme (GBM) treatment market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glioblastoma multiforme (gbm) treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Glioblastoma Multiforme (GBM) Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8803&type=smp

Browse Through More Reports Similar to the Global Glioblastoma Multiforme (GBM) Treatment Market 2026, By The Business Research Company

Glioblastoma Multiforme Global Market Report

https://www.thebusinessresearchcompany.com/report/glioblastoma-multiforme-global-market-report

Glioma Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report

Adult Malignant Glioma Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/adult-malignant-glioma-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795